The EWS/FLI Oncogene Drives Changes in Cellular Morphology, Adhesion, and Migration in Ewing Sarcoma

Genes and Cancer

Volumn 3, Issue 2, 2012, Pages 102-116

  Chaturvedi, Aashi ^a,b   Hoffman, Laura M ^a,c   Welm, Alana L ^a,b   Lessnick, Stephen L ^a,b   Beckerle, Mary C ^a,b,c  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

cell adhesion; cytoskeleton; Ewing sarcoma; EWS FLI; metastasis

Indexed keywords

RNA BINDING PROTEIN EWS; TRANSCRIPTION FACTOR FLI 1;

ACTIN FILAMENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL SPREADING; CELL STRUCTURE; CONTROLLED STUDY; EWING SARCOMA; EWS FLI GENE; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MIGRATION INHIBITION; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; STRESS FIBER;

EID: 84869843232     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601912457024     Document Type: Article

References (67)

1. Valastyan S,Weinberg RA.Tumor metastasis: molecular insights and evolving paradigms.Cell. 2011;147:275-92.
2. Chaffer CL,Weinberg RA.A perspective on cancer cell metastasis.Science. 2011;331:1559-64.
3. Nguyen DX,Bos PD,Massague J.Metastasis: from dissemination to organ-specific colonization.Nat Rev Cancer. 2009;9:274-84.
4. Yang J,Weinberg RA.Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.Dev Cell. 2008;14:818-29.
5. Guilford P,Hopkins J,Harraway J, et al.E-cadherin germline mutations in familial gastric cancer.Nature. 1998;392:402-5.
6. Vincent-Salomon A,Thiery JP.Host microenvironment in breast cancer development: epithelial-mesenchymal transition in breast cancer development.Breast Cancer Res. 2003;5:101-6.
7. Perl AK,Wilgenbus P,Dahl U, et al.A causal role for E-cadherin in the transition from adenoma to carcinoma.Nature. 1998;392:190-3.
8. Frixen UH,Behrens J,Sachs M, et al.E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.J Cell Biol. 1991;113:173-85.
9. Guo W,Giancotti FG.Integrin signalling during tumour progression.Nat Rev Mol Cell Biol. 2004;5:816-26.
10. Rathinam R,Alahari SK.Important role of integrins in the cancer biology.Cancer Metastasis Rev. 2010;29:223-37.
11. Kumar S,Weaver VM.Mechanics, malignancy, and metastasis: the force journey of a tumor cell.Cancer Metastasis Rev. 2009;28:113-27.
12. Talmadge JE,Fidler IJ.AACR centennial series: the biology of cancer metastasis: historical perspective.Cancer Res. 2010;70:5649-69.
13. Eyles J,Puaux AL,Wang X, et al.Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma.J Clin Invest. 2010;120:2030-9.
14. Fearon ER,Vogelstein B.A genetic model for colorectal tumorigenesis.Cell. 1990;61:759-67.
15. Fidler IJ,Kripke ML.Metastasis results from preexisting variant cells within a malignant tumor.Science. 1977;197:893-5.
16. Pantel K,Alix-Panabieres C,Riethdorf S.Cancer micrometastases.Nat Rev Clin Oncol. 2009;6:339-51.
17. Wikman H,Vessella R,Pantel K.Cancer micrometastasis and tumour dormancy.APMIS. 2008;116:754-70.
18. Ramaswamy S,Ross KN,Lander ES, et al.A molecular signature of metastasis in primary solid tumors.Nat Genet. 2003;33:49-54.
19. Spraker HL,Price SL,Chaturvedi A, et al.The clone wars-revenge of the metastatic rogue state: the sarcoma paradigm.Front Oncol. 2012;2:2.
20. Dahlin DC,Coventry MB,Scanlon PW.Ewing's sarcoma: a critical analysis of 165 cases.J Bone Joint Surg Am. 1961;43-A:185-92.
21. Wang CC,Schulz MD.Ewing's sarcoma; a study of fifty cases treated at the Massachusetts General Hospital, 1930-1952 inclusive.N Engl J Med. 1953;248:571-6.
22. Dubois SG,Epling CL,Teague J, et al.Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow.Pediatr Blood Cancer. 2010;54:13-8.
23. Peter M,Magdelenat H,Michon J, et al.Sensitive detection of occult Ewing's cells by the reverse transcriptase-polymerase chain reaction.Br J Cancer. 1995;72:96-100.
24. Pfleiderer C,Zoubek A,Gruber B, et al.Detection of tumour cells in peripheral blood and bone marrow from Ewing tumour patients by RT-PCR.Int J Cancer. 1995;64:135-9.
25. Zoubek A,Kovar H,Kronberger M, et al.Mobilization of tumour cells during biopsy in an infant with Ewing sarcoma.Eur J Pediatr. 1996;155:373-6.
26. West DC,Grier HE,Swallow MM, et al.Detection of circulating tumor cells in patients with Ewing's sarcoma and peripheral primitive neuroectodermal tumor.J Clin Oncol. 1997;15:583-8.
27. de Alava E,Lozano MD,Patino A, et al.Ewing family tumors: potential prognostic value of reverse-transcriptase polymerase chain reaction detection of minimal residual disease in peripheral blood samples.Diagn Mol Pathol. 1998;7:152-7.
28. Fagnou C,Michon J,Peter M, et al.Presence of tumor cells in bone marrow but not in blood is associated with adverse prognosis in patients with Ewing's tumor. Societe Francaise d'Oncologie Pediatrique.J Clin Oncol. 1998;16:1707-11.
29. Fidelia-Lambert MN,Zhuang Z,Tsokos M.Sensitive detection of rare Ewing's sarcoma cells in peripheral blood by reverse transcriptase polymerase chain reaction.Hum Pathol. 1999;30:78-80.
30. Aurias A,Rimbaut C,Buffe D, et al.Translocation involving chromosome 22 in Ewing's sarcoma: a cytogenetic study of four fresh tumors.Cancer Genet Cytogenet. 1984;12:21-5.
31. Delattre O,Zucman J,Plougastel B, et al.Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours.Nature. 1992;359:162-5.
32. Turc-Carel C,Philip I,Berger MP, et al.Chromosome study of Ewing's sarcoma (ES) cell lines: consistency of a reciprocal translocation t(11;22)(q24;q12).Cancer Genet Cytogenet. 1984;12:1-19.
33. Sankar S,Lessnick SL.Promiscuous partnerships in Ewing's sarcoma.Cancer Genet. 2011;204:351-65.
34. May WA,Lessnick SL,Braun BS, et al.The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1.Mol Cell Biol. 1993;13:7393-8.
35. Kinsey M,Smith R,Lessnick SL.NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.Mol Cancer Res. 2006;4:851-9.
36. Owen LA,Kowalewski AA,Lessnick SL.EWS/FLI mediates transcriptional repression via NKX2.2 during oncogenic transformation in Ewing's sarcoma.PLoS One. 2008;3:e1965.
37. Prieur A,Tirode F,Cohen P, et al.EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3.Mol Cell Biol. 2004;24:7275-83.
38. Smith R,Owen LA,Trem DJ, et al.Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma.Cancer Cell. 2006;9:405-16.
39. Amsellem V,Kryszke MH,Hervy M, et al.The actin cytoskeleton-associated protein zyxin acts as a tumor suppressor in Ewing tumor cells.Exp Cell Res. 2005;304:443-56.
40. Jaishankar S,Zhang J,Roussel MF, et al.Transforming activity of EWS/FLI is not strictly dependent upon DNA-binding activity.Oncogene. 1999;18:5592-7.
41. Song Y,Maul RS,Gerbin CS, et al.Inhibition of anchorage-independent growth of transformed NIH3T3 cells by epithelial protein lost in neoplasm (EPLIN) requires localization of EPLIN to actin cytoskeleton.Mol Biol Cell. 2002;13:1408-16.
42. Lessnick SL,Braun BS,Denny CT, et al.Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.Oncogene. 1995;10:423-31.
43. May WA,Gishizky ML,Lessnick SL, et al.Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation.Proc Natl Acad Sci U S A. 1993;90:5752-6.
44. Braunreiter CL,Hancock JD,Coffin CM, et al.Expression of EWS-ETS fusions in NIH3T3 cells reveals significant differences to Ewing's sarcoma.Cell Cycle. 2006;5:2753-9.
45. Hancock JD,Lessnick SL.A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signature.Cell Cycle. 2008;7:250-6.
46. Cavazzana AO,Miser JS,Jefferson J, et al.Experimental evidence for a neural origin of Ewing's sarcoma of bone.Am J Pathol. 1987;127:507-18.
47. Ewing J.Diffuse endothelioma of bone.Proc NY Pathol Soc. 1921;21:17-24.
48. Tirode F,Laud-Duval K,Prieur A, et al.Mesenchymal stem cell features of Ewing tumors.Cancer Cell. 2007;11:421-9.
49. Kovar H.Context matters: the hen or egg problem in Ewing's sarcoma.Semin Cancer Biol. 2005;15:189-96.
50. Owen LA,Lessnick SL.Identification of target genes in their native cellular context: an analysis of EWS/FLI in Ewing's sarcoma.Cell Cycle. 2006;5:2049-53.
51. Martinez-Ramirez A,Rodriguez-Perales S,Melendez B, et al.Characterization of the A673 cell line (Ewing tumor) by molecular cytogenetic techniques.Cancer Genet Cytogenet. 2003;141:138-42.
52. Turner CE.Paxillin and focal adhesion signalling.Nat Cell Biol. 2000;2:E231-6.
53. Riggi N,Suva ML,Suva D, et al.EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells.Cancer Res. 2008;68:2176-85.
54. Herrero-Martin D,Osuna D,Ordonez JL, et al.Stable interference of EWS-FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target.Br J Cancer. 2009;101:80-90.
55. Eshghi S,Vogelezang MG,Hynes RO, et al.Alpha4beta1 integrin and erythropoietin mediate temporally distinct steps in erythropoiesis: integrins in red cell development.J Cell Biol. 2007;177:871-80.
56. Patel VP,Lodish HF.Loss of adhesion of murine erythroleukemia cells to fibronectin during erythroid differentiation.Science. 1984;224:996-8.
57. Patel VP,Ciechanover A,Platt O, et al.Mammalian reticulocytes lose adhesion to fibronectin during maturation to erythrocytes.Proc Natl Acad Sci U S A. 1985;82:440-4.
58. Kimber C,Michalski A,Spitz L, et al.Primitive neuroectodermal tumours: anatomic location, extent of surgery, and outcome.J Pediatr Surg. 1998;33:39-41.
59. Shibue T,Weinberg RA.Metastatic colonization: settlement, adaptation and propagation of tumor cells in a foreign tissue environment.Semin Cancer Biol. 2011;21:99-106.
60. Sterling JA,Edwards JR,Martin TJ, et al.Advances in the biology of bone metastasis: how the skeleton affects tumor behavior.Bone. 2011;48:6-15.
61. Girnita L,Girnita A,Wang M, et al.A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells.Oncogene. 2000;19:4298-301.
62. Luo W,Gangwal K,Sankar S, et al.GSTM4 is a microsatellite- containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.Oncogene. 2009;28:4126-32.
63. Kauer M,Ban J,Kofler R, et al.A molecular function map of Ewing's sarcoma.PLoS One. 2009;4:e5415.
64. Tirado OM,Mateo-Lozano S,Villar J, et al.Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells.Cancer Res. 2006;66:9937-47.
65. Lessnick SL,Dacwag CS,Golub TR.The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts.Cancer Cell. 2002;1:393-401.
66. Hoffman LM,Jensen CC,Kloeker S, et al.Genetic ablation of zyxin causes Mena/VASP mislocalization, increased motility, and deficits in actin remodeling.J Cell Biol. 2006;172:771-82.
67. Padua D,Zhang XH,Wang Q, et al.TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4.Cell. 2008;133:66-77.